Issue: Volume VIII No. 1 - January 15, 2001

Two Labs Complete IPOs, AML May be Next in Line

CEO SUMMARY: During the year 2000, investors liked the performance of clinical labs. When stock market woes surfaced this fall, it was not enough to dampen investor interest in Dynacare and Specialty Laboratories. Both companies funded their initial public stock offering in a difficult market. Still on deck is American Medical Laboratories. It has yet …

Two Labs Complete IPOs, AML May be Next in Line Read More »

Dynacare’s Business Plan Includes New Direction

CEO SUMMARY: Look for Dynacare, Inc. to undergo a significant transformation. Although it will not abandon its efforts to partner with hospital laboratories, Dynacare has made a renewed commitment to expand and market itself as a provider of esoteric and reference testing. These changes are a result of the extensive strategic planning required to prepare …

Dynacare’s Business Plan Includes New Direction Read More »

Number of Hospital Deals Declines Again in 2000

CEO SUMMARY: Probably the single biggest contributing factor to consolidation of hospital laboratories is when new owners or new healthcare systems take control of a hospital. For 2000, merger and acquisition activity in the hospital industry declined in 2000 by 40%. A total of 318 hospitals were involved in the 129 deals. This decline in …

Number of Hospital Deals Declines Again in 2000 Read More »

Consumers Taking Active Role In Their Laboratory Testing

CEO SUMMARY: Two recent Internet surveys revealed that consumers rank access to their personal lab test results as the number one most wanted feature in healthcare services. This is an early warning for laboratories and pathology group practices. Today’s consumers have changing expectations about the types of services they want their clinical laboratory to provide. …

Consumers Taking Active Role In Their Laboratory Testing Read More »

HIPAA Hits Radar Screen, Expected to be Expensive

CEO SUMMARY: HIPAA is beginning to generate controversy as implementation dates are announced. The American Hospital Association is painting a black picture, despite protestations of certain experts. Meanwhile, managed care companies are finding it difficult to come together and form a unified lobbying effort. All the signs point to a rancorous public debate on important …

HIPAA Hits Radar Screen, Expected to be Expensive Read More »

DNA Diagnostics Market, Kaiser Permanente, TriPath Imaging, LifeScan

DNA DIAGNOSTICS MARKET GROWTH TO BE DOMINATED BY PCR TECHNOLOGY FOR THE YEAR 2000, total DNA diagnostic technology sales were estimated to be $517 million. By 2005, this number should increase to $771 million, a growth rate of 8.4% per year. This is the conclusion of Laura Roth, author of “The DNA Diagnostics Market,” a …

DNA Diagnostics Market, Kaiser Permanente, TriPath Imaging, LifeScan Read More »

“January 15, 2001 Intelligence: Late Breaking Lab News”

In Cincinnati, the CHIN (community healthcare information network) effort of the mid-1990s has evolved into HealthBridge, a “secure, private Intranet that provides physician access to hospital clinical records, insurance eligibility, e-mail, and on-line medical reference material.” Three of the larger health systems in Cincinnati, representing 20 hospitals, are participating. In recent months, the first hospitals …

“January 15, 2001 Intelligence: Late Breaking Lab News” Read More »

Powered by Americaneagle.com

Hosted by Americaneagle.com, Inc.